UK accepts all 44 recommendations for regulating AI in healthcare

On October 6, 2026, the UK government accepted all 44 recommendations of the National Commission into the Regulation of AI in Healthcare and said the MHRA would issue draft guidance by December on managing changes to adaptive AI-enabled medical devices. The response moves the UK’s principles-led approach toward a lifecycle model involving post-market monitoring, cross-regulator coordination and clearer treatment of systems that change after deployment. For legal teams in healthcare, life sciences and technology, this makes change control, performance monitoring and regulatory ownership core contracting issues rather than post-launch technical matters. Firms should watch whether the resulting assurance model becomes a template for other high-impact sectors.